A 64-year-old man with long-standing hypertension and hyperlipidaemia has an absolute 5-year CVD risk of 18% on the Aus CVD Risk Calculator. He is a non-smoker and already takes perindopril and atorvastatin at maximal tolerated doses with reasonable adherence. According to Australian risk guidelines, which additional intervention has the strongest evidence for further risk reduction?